Can Menopause Cause Hip Bursitis?

Menopause is a natural biological transition defined by a significant shift in hormone levels, particularly the decline of estrogen, which impacts systems throughout the body. Many women experience new or worsening musculoskeletal discomfort during this time, leading to questions about a connection between hormonal changes and conditions like hip bursitis. The evidence suggests a clear link, where the menopausal transition creates a biological and mechanical environment that increases the susceptibility to this common source of outer hip pain.

Understanding Trochanteric Bursitis

Trochanteric bursitis is the most frequent form of hip bursitis, involving the inflammation of a fluid-filled sac called a bursa. Bursae act as small cushions between bones, tendons, and muscles to reduce friction during movement. The trochanteric bursa is specifically located over the greater trochanter, the large bony bump on the outer side of the upper thigh bone.

When this bursa becomes irritated or damaged, it swells and causes pain. The pain is typically felt as a tenderness or ache on the outside of the hip and upper thigh. Symptoms often worsen when lying directly on the affected side or when performing activities that stress the hip, such as rising from a low chair or climbing stairs. Friction and pressure from repetitive motion or direct trauma are the usual triggers for this inflammation.

The Direct Role of Estrogen in Joint and Tendon Health

Estrogen plays a protective and regulatory role in the health of connective tissues. Receptors for estrogen are present in these tissues, where the hormone helps to regulate the production and quality of collagen. Collagen is the main protein providing structural support and elasticity to connective tissue.

The sharp decline in circulating estrogen during menopause disrupts this balance, leading to a decrease in collagen synthesis and changes in its structure. This can make the tendons and other soft tissues surrounding the hip joint less resilient and more susceptible to micro-trauma. Tissues that are less elastic are more likely to fray or become irritated under normal mechanical stress, which directly increases the risk of inflammation in the adjacent trochanteric bursa.

Estrogen also possesses anti-inflammatory properties, helping to moderate the body’s overall inflammatory response. With lower estrogen levels, this anti-inflammatory protection is diminished, leading to a state where inflammation can become more easily triggered and sustained. This systemic change means that any minor irritation to the hip area, which might have previously resolved quickly, is now more likely to progress into a painful and persistent condition like bursitis.

Systemic Changes That Increase Bursitis Risk

Menopause introduces systemic physical changes that place greater mechanical stress on the hip joint. A common change is the redistribution of body fat, often resulting in increased central or abdominal obesity. This shift alters the body’s center of gravity and can subtly change a person’s gait, or walking pattern, increasing the load and friction on the outer hip structures.

The decline in estrogen also accelerates the loss of muscle mass and strength, a condition known as sarcopenia. The gluteal muscles, which attach near the greater trochanter, are crucial for stabilizing the hip and pelvis during standing and walking. Weakness in these hip abductor muscles can lead to instability and abnormal movement patterns, creating excessive compression and friction on the trochanteric bursa.

Clinical Diagnosis and Targeted Management Strategies

Diagnosis of trochanteric bursitis typically begins with a thorough physical examination, where a doctor checks for tenderness directly over the greater trochanter. Imaging, such as X-rays, is generally used to rule out other potential sources of hip pain, including hip joint arthritis or bone spurs. An ultrasound or Magnetic Resonance Imaging (MRI) may be used to confirm the presence of bursal inflammation or associated tendon changes.

Management focuses on non-surgical interventions. Nonsteroidal anti-inflammatory drugs (NSAIDs) can help manage the immediate pain and swelling. Physical therapy is a primary intervention, concentrating on strengthening the weakened gluteal muscles and improving hip flexibility to reduce mechanical strain on the bursa.

Lifestyle adjustments, such as using a pillow between the knees when sleeping on the side, are often recommended to alleviate pressure on the hip. For persistent symptoms, a corticosteroid injection directly into the bursa can provide substantial relief by delivering a potent anti-inflammatory agent. Hormone replacement therapy (HRT) can also be considered, as it may improve joint pain and connective tissue health by restoring some of estrogen’s protective effects.